Q2 2025 Holdings
Filed 2025-08-13 | 59 holdings | $101.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adma Biologics Inc(ADMA) | COM | 000899104 | $13.7M | 750,000 | 13.4% |
| Evolus Inc(EOLS) | COM | 30052C107 | $8.4M | 916,500 | 8.3% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $6.8M | 775,620 | 6.7% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $5.6M | 1,360,386 | 5.5% |
| Indivior PLC(INDV) | ORD | G4766E116 | $5.2M | 350,000 | 5.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.9M | 225,000 | 4.8% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $4.6M | 604,066 | 4.5% |
| Tela BIO Inc(TELA) | COM | 872381108 | $4.0M | 2,083,762 | 4.0% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $3.8M | 152,143 | 3.8% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $3.1M | 310,033 | 3.0% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $2.9M | 450,000 | 2.9% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $2.7M | 306,029 | 2.7% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $2.5M | 38,597 | 2.5% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $2.2M | 555,000 | 2.1% |
| Anika Therapeutics Inc(ANIK) | COM | 035255108 | $2.0M | 190,590 | 2.0% |
| Aytu Biopharma Inc(AYTU) | COM | 054754858 | $1.8M | 812,676 | 1.7% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $1.4M | 733,793 | 1.4% |
| Geron Corp(GERN) | COM | 374163103 | $1.4M | 1,000,000 | 1.4% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $1.4M | 657,380 | 1.3% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $1.3M | 50,200 | 1.3% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $1.3M | 285,300 | 1.3% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $1.2M | 41,500 | 1.2% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $1.2M | 250,000 | 1.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.1M | 100,000 | 1.1% |
| Alumis Inc(ALMS) | COM | 022307102 | $1.0M | 349,615 | 1.0% |
| Myomo Inc(MYO) | COM NEW | 62857J201 | $988.0K | 457,419 | 1.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $976.7K | 219,000 | 1.0% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $957.8K | 205,100 | 0.9% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $896.7K | 845,968 | 0.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $870.0K | 92,900 | 0.9% |
| Grace Therapeutics Inc(GRCE) | COM | 00439U104 | $868.7K | 292,500 | 0.9% |
| Kezar Life Sciences Inc(KZR) | COM NEW | 49372L209 | $778.0K | 169,859 | 0.8% |
| Angiodynamics Inc(ANGO) | COM | 03475V101 | $765.2K | 77,141 | 0.8% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $753.3K | 333,333 | 0.7% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $697.6K | 491,300 | 0.7% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $655.2K | 130,000 | 0.6% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $624.0K | 151,085 | 0.6% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $623.0K | 50,000 | 0.6% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $577.2K | 544,494 | 0.6% |
| Kiora Pharmaceuticals Inc(KPRX) | COM | 49721T507 | $512.6K | 178,000 | 0.5% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $455.0K | 156,888 | 0.4% |
| Hillevax Inc | COM | 43157M102 | $449.8K | 226,009 | 0.4% |
| Theratechnologies Inc(TQ80) | COM NEW | 88338H704 | $446.2K | 189,051 | 0.4% |
| Verastem Inc(VSTM)Call | COM NEW | 92337C203 | $415.0K | 100,000 | 0.4% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $377.9K | 145,900 | 0.4% |
| Health Catalyst Inc(HCAT) | COM | 42225T107 | $377.0K | 100,000 | 0.4% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $299.0K | 7,000 | 0.3% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $297.6K | 30,000 | 0.3% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $255.6K | 45,000 | 0.3% |
| Savara Inc(SVRA) | COM | 805111101 | $193.8K | 85,000 | 0.2% |